Serial Number 76682428
Registration 3771913
800

Registration Progress

Application Filed
Oct 1, 2007
Under Examination
Nov 11, 2008
Approved for Publication
Jul 30, 2008
Published for Opposition
Aug 19, 2008
Registered
Apr 6, 2010

Trademark Image

Basic Information

Serial Number
76682428
Registration Number
3771913
Filing Date
October 1, 2007
Registration Date
April 6, 2010
Published for Opposition
August 19, 2008
Renewal Date
April 6, 2020
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 3, 2019
Registration
Registered
Classes
005

Rights Holder

ZHEJIANG MEDICINE CO.,LTD

99
Address
168 Mid Zhiyuan Ave., Binhai New Area,
SHAOXING, ZHEJIANG, 312366
CN

Ownership History

ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY

Original Applicant
03
Xinchang Zhejiang CN

ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY

Owner at Publication
03
Xinchang Zhejiang CN

ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY

Original Registrant
03
Xinchang Zhejiang CN

ZHEJIANG MEDICINE CO.,LTD

New Owner After Registration #1
99
SHAOXING, ZHEJIANG, CN

USPTO Deadlines

Next Deadline
1526 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20100406)
Due Date
April 06, 2030
Grace Period Ends
October 06, 2030

Application History

50 events
Date Code Type Description Documents
Jun 3, 2019 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 3, 2019 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jun 3, 2019 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 3, 2019 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
May 17, 2019 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
May 17, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 24, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 18, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 18, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 6, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jan 5, 2017 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Jan 5, 2017 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Jan 5, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 27, 2016 ES8R I TEAS SECTION 8 RECEIVED Loading...
Sep 27, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 6, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 1, 2010 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Feb 22, 2010 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 22, 2010 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Feb 22, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 19, 2010 MAIL I PAPER RECEIVED Loading...
Oct 27, 2009 CNRT O NON-FINAL ACTION MAILED Loading...
Oct 26, 2009 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Oct 23, 2009 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 6, 2009 IUAF S USE AMENDMENT FILED Loading...
Oct 23, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 6, 2009 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 28, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 28, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 28, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 11, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 19, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 30, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Jul 17, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 16, 2008 ALIE A ASSIGNED TO LIE Loading...
Jul 14, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 14, 2008 CNEA O EXAMINERS AMENDMENT MAILED Loading...
Jul 14, 2008 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 14, 2008 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 10, 2008 CNFR O FINAL REFUSAL MAILED Loading...
Jul 9, 2008 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 2, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 11, 2008 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jun 11, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 10, 2008 FAXX I FAX RECEIVED Loading...
Jan 10, 2008 CNRT F NON-FINAL ACTION MAILED Loading...
Jan 10, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 7, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 24, 2007 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Nov 21, 2007 ALIE A ASSIGNED TO LIE Loading...

Detailed Classifications

Class 005
Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets; ace-inhibitors; adrenergic agonists; adrenergic blockers; anabolics; analgesics, narcotic and non-narcotic analgesics; anesthetics; antianorexics; antacids; anthelmintics; antiacnes; antiallergics; antianginals; antiarthritics and antirheumatics; antiasthmatics; antibacterials; antibiotics; anticoagulants; anticonvulsants; antidepressants; antidiabetics; antidiarrheals; antidiuretics; antiemetics; antifungals; antiglaucomas; antihistaminics; antihypertensives; antihyperthyroids; antihypotensives; anti-inflammatories; anti-itch creams, ointments and sprays; antimalarials; antimigraines; antimuscarinics; antineoplastics; antioxidants; antiparkinsonians; antiprotozoals; antipruritics; antipsoriatics; antipsychotics; antiseborrheics; antiseptics; antispasmodics; antisyphilitics; antithrombotics; antitussives; antiulceratives; antivirals; anxiolyties; astringents; bacteriostats for medicinal, dental and veterinary use; bath salts for medical purposes; beta-blockers; biocides; biological and chemical reagents for medical or veterinary use; bronchodilators; burn-relief medications; calcium channel blockers; cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; chemotherapeutics; choleretics; cholesterol reducers; cholinergics; cholinesterase inhibitors; cleansing solutions for medical use; clinical medical reagents; CNS stimulants; contraceptives; decongestants; dermatologicals; diagnostic preparations for medical purposes; dietary and nutritional supplements; diuretics; dopamine receptor agonists; enzyme cofactors; estrogens; expectorants; food supplements; gastric and pancreatic preparations; germicides; glucosidase inhibitors; gonad-stimulating principles; hematinics; hematopoietics; hemostatics; hepatoprotectants; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; homeopathic supplements; immunomodulators; immunosuppressants; laxatives; medicinal herbal extracts; mineral nutritional supplements; mineralocorticoids; mixed vitamin preparations; mucolytics; multi-vitamin preparations; muscle relaxants; mydriatics; neutraceuticals for use as dietary supplements; nootropics; nutritional additives to foodstuffs for animals, for medical purposes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; plant extracts for medical, veterinary and pharmaceutical purposes; processed food adapted for medical purposes; progestogens; prolactin inhibitors; prostaglandins and prostaglandin analogs; dietary supplements; respiratory stimulants; reverse transcriptase inhibitors; sedatives; seratonin receptor agonists and antagonists; soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; vasodilators; vasoprotectants; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
First Use Anywhere: Jun 17, 2009
First Use in Commerce: Jun 17, 2009

Additional Information

Design Mark
The mark consists of a triangle having an upper part and a lower part. The upper part is a light blue field surrounding a white triangle and the lower part is a dark blue field surrounding two white triangles.
Color Claim
The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.

Classification

International Classes
005